← All diseases Cancer

Mesothelioma

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (25)Meta-analysis (7)Treatment guideline (2)Systematic review (9)Phase 3 study (5)Randomized trial (2)Clinical trial (596)Review article (164)Early study (phase 1 or 2) (46)Case report (164)Laboratory or animal study (30)Commentary or editorial (70)Concerns have been raised (1)Retracted publication (1) Studies currently recruiting participants only (31)

Filter

Publications and studies (1693)

• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Isolated Peripheral Nervous System Presentation in Ma/Ma2-Associated Autoimmunity. (2026/09/01) ♡
• Five-Year Trends in Biomarker Testing and Targeted Therapy for NSCLC: A Patient-Initiated Nationwide Survey in Japan. (2026/08/07) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Surgical Management of a Pediatric Case of Metastatic Mesothelioma of the Tunica Vaginalis. (2026/08/05) ♡
• Retraction Note: A novel malignant mesothelioma organoids-T cell co-culture platform for personalized immunochemotherapy testing. (2026/08/04) ♡
• A novel tRNA-derived small RNA tsRNA-Ile-5-0044 is a candidate biomarker for laryngeal squamous cell carcinoma. (2026/08/02) ♡
• A Monte Carlo simulation for evaluating hypothetical mesothelioma risk in a person exposed to talcum powder. (2026/08/01) ♡
• Genome-wide copy number analysis identifies AKT as a novel therapeutic target in pleural mesothelioma. (2026/08/01) ♡
• Outcomes of Immune Check Point Inhibitor Use in US Veterans With Pre-Existing Idiopathic Inflammatory Myopathies: Case Series and Literature Review. (2026/08/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Insights Into Genomic Drivers, Transcriptomic Heterogeneity, and Therapeutic Vulnerabilities From Novel Mesothelioma Cell Lines. (2026/08/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Do People Occupationally Exposed to Asbestos-Free Talc Have Elevated Risk for Lung Cancer, Laryngeal Cancer, or Mesothelioma? (2026/08/01) ♡
• AZ'4331 is a novel pan-TEAD auto-palmitoylation inhibitor for the treatment of Hippo pathway-altered cancers. (2026/07/29) ♡
• Successful Diagnostic Confirmation of Malignant Pleural Mesothelioma With Extensive Pleural Adhesions Using Pleural Cryobiopsy Under Local Anaesthesia. (2026/07/29) ♡
• Low baseline cGAS expression is associated with longer progression-free survival in patients with pleural mesothelioma. (2026/07/28) ♡
• Qualitative insights into patient and carer perspectives of malignant pleural effusion management: an embedded study within the TACTIC trial. (2026/07/27) ♡
• External validation of dose to heart substructures and the association with non-cancer death after SBRT in stage I-II NSCLC patients. (2026/07/26) ♡
• Efficacy of Perioperative Platinum-Pemetrexed Chemotherapy Combined with Pleurectomy/Decortication for Pleural Mesothelioma. (2026/07/25) ♡
• ASO Visual Abstract: Treatment for Oligo-recurrence of Diffuse Pleural Mesothelioma After Extended Pleurectomy/Decortication. (2026/07/25) ♡
• Peritoneal mesothelioma showing a remarkable response to nivolumab plus ipilimumab in a patient with Lynch syndrome: A case report and literature review. (2026/07/25) ♡
• Brief report: attitudes and barriers toward genetic testing in pleural mesothelioma: a nationwide Italian survey. (2026/07/24) ♡
• The Prognostic Significance of BRCA1-Associated Protein 1(BAP1) in Malignant Pleural Mesothelioma: A Systematic Review and Meta-Analysis. (2026/07/24) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Well-Differentiated Papillary Mesothelioma in a Child With SOS1-Related Noonan Syndrome. (2026/07/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Giant Omental Lymphangioma Presenting With Abdominal Pain and Intra-Cystic Hemorrhage in an Adult: A Case Report. (2026/07/22) ♡
• Disaster-Related Medical Geology Research: A Bibliometric Mapping of Geogenic Exposure Pathways and Earth-Health Integration (1980-2025). (2026/07/22) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Chylopericardium in a Dog with Concurrent Chylothorax, Mesothelioma, and Bilateral Brachiocephalic Vein Thrombosis: A Case Report. (2026/07/22) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case of well-differentiated papillary mesothelial tumor concomitant with primary gastric cancer: case report and literature review. (2026/07/22) ♡
• Epidemiological and Prognostic Differences in Malignant Mesothelioma Between Eastern China and SEER Database. (2026/07/21) ♡
• Treatment for Oligo-recurrence of Diffuse Pleural Mesothelioma After Extended Pleurectomy/Decortication. (2026/07/20) ♡
• Epiproteomic profiling identifies histone H4 hyperacetylation as a prognostic marker in pleural mesothelioma. (2026/07/19) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Research progress on the regulation of mesothelioma driven by deubiquitinating enzyme BAP1. (2026/07/17) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial Note: In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma. (2026/07/16) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Serous fluid cytopathology: landmark developments in techniques, terminology & clinical application. (2026/07/16) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Maintenance pemetrexed after platinum pemetrexed chemotherapy and survival outcomes in malignant pleural mesothelioma in a multicenter real world study. (2026/07/15) ♡
• Simultaneous Occurrence of Well-Differentiated Papillary Mesothelial Tumor and Multicystic Mesothelioma. (2026/07/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Involvement of lysosomal proteins in morphology-driven toxicity of (nano)fibers. (2026/07/14) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial Note: Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma. (2026/07/14) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer. (2026/07/14) ♡
• Primary Malignant Pericardial Epithelioid Mesothelioma Presenting as Cardiac Tamponade: A Case Report With Multimodality Imaging and Radiologic-Pathologic Correlation. (2026/07/12) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Beyond Statistical Significance: Methodological Fragility and Censoring Bias in the 5-Year Update of CheckMate 743. (2026/07/10) ♡
• Prognostic impact of somatic mutations among patients with pleural and peritoneal mesothelioma. (2026/07/09) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary thymic papillary adenocarcinoma with a rare CD5/CD117-negative and PAX8/WT1-positive immunophenotype: A case report. (2026/07/09) ♡
• Glycan Fingerprint of Malignant Pleural Mesothelioma. (2026/07/09) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Localized Epithelioid Peritoneal Mesothelioma: A Rare Mimicker of Gynecological Malignancy. (2026/07/08) ♡
• Correction to "Thiolate DNAzymes on Gold Nanoparticles for Isothermal Amplification and Detection of Mesothelioma-derived Exosomal PD-L1 mRNA". (2026/07/07) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Multicystic peritoneal mesothelioma mimicking recurrent pseudomyxoma peritonei. (2026/07/07) ♡
• Third French Congress on Mesothelioma. (2026/07/06) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. TEAD inhibitor induced switch in energy metabolism drives human podocyte injury in vitro. (2026/07/06) ♡
• Diagnostic value of biochemical ratios in the differential diagnosis of tuberculous and malignant pleural effusions. (2026/07/03) ♡
• Pan-cancer Bioinformatics Analysis Combined with Colon Cancer Experimental Validation: A Study on TMED3 as a Diagnostic and Prognostic Biomarker. (2026/07/03) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Networking is Essential for the Proper Management of Rare Cancers: From Recognition to Implementation. (2026/07/02) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. CHIMERA: A Phase II Study of Neoadjuvant Pembrolizumab in Combination With Cisplatin or Carboplatin and Pemetrexed Followed by Surgery and Adjuvant Pembrolizumab in Resectable Pleural Mesothelioma. (2026/07/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.